KR101424192B1 - Composition for Hot-start PCR Comprising Blocking Oligonucleotide - Google Patents
Composition for Hot-start PCR Comprising Blocking Oligonucleotide Download PDFInfo
- Publication number
- KR101424192B1 KR101424192B1 KR20110017226A KR20110017226A KR101424192B1 KR 101424192 B1 KR101424192 B1 KR 101424192B1 KR 20110017226 A KR20110017226 A KR 20110017226A KR 20110017226 A KR20110017226 A KR 20110017226A KR 101424192 B1 KR101424192 B1 KR 101424192B1
- Authority
- KR
- South Korea
- Prior art keywords
- pcr
- primer
- blocking oligonucleotide
- reaction
- blocking
- Prior art date
Links
- AGISJCNBNXVCQZ-UHFFFAOYSA-N CP(O)(OCCCCCCN)=O Chemical compound CP(O)(OCCCCCCN)=O AGISJCNBNXVCQZ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
Abstract
The present invention relates to a composition for hot start PCR, and more particularly, to a composition for PCR comprising a reaction buffer solution, MgCl 2 , four kinds of dNTPs, and a DNA polymerase, wherein the hydroxyl group at the 3 'end is blocked, The present invention relates to a composition for hot start PCR, which comprises a blocking oligonucleotide having a base sequence. Since the composition for hot start PCR of the present invention dissociates the blocking oligonucleotide at a temperature lower than the melting temperature of the primer, primer-dimer formation at a low temperature or the attraction of the PCR amplification product due to nonspecific reaction is suppressed, The result can be obtained.
Description
The present invention relates to a composition for a hot start PCR comprising a blocking oligonucleotide (sometimes referred to as "blocking oligonucleotide" hereinafter), and more particularly, to a composition for blocking a 3 'end of a conventional PCR composition, And further comprising a predetermined concentration of a blocking oligonucleotide having a complementary base sequence.
The specificity in the PCR reaction is determined by the high stringency of primers that bind to the target gene sequence. However, all the components required for gene amplification during PCR are mixed at room temperature before the initial denaturation of the gene, so that priming of low string expression occurs under this condition. Priming of these low stringency primers, along with the complexity of the target DNA sequence, low reaction temperature, etc., is a major factor in increasing nonspecific amplification, since the activity of the polymerase is maintained at low temperatures, And nonspecific amplification consumes primers and other required components of limited concentration in repeated PCR, resulting in a competitive inhibitor. Nonspecific amplification has been pointed out as a major problem especially in performing low number of copy number target DNA detection, amplification of low concentration DNA sample, and multiplux PCR using various primers simultaneously.
"Hot start PCR" has been developed as a result of efforts to solve these problems in general PCR. Hot start PCR is one of the methods for obtaining more accurate PCR products. By mixing the reactants at high temperature conditions, priming of low stringency occurring at room temperature and thereby preventing oligomerization of nonspecific primers, . ≪ / RTI >
The simplest method of performing hot start PCR is to open hot reaction tubes and add the missing components, but this method has the disadvantage of exposing the reaction mixture to contamination, forming aerosols, and causing evaporation. Another hot start PCR method is to create a necessary component, for example, a physical blocking film between the primer and the template. Among these barrier films, paraffin wax has usually been used as an electrophysical barrier film. That is, when the paraffin wax is covered on the reaction mixture and the wax is hardened, a reagent (starting reagent) is added thereto, and then mineral oil is added and the temperature of the gene amplifying device is raised to 70 to 90 ° C., And the starting reagent are mixed, and the PCR reaction proceeds. As such, since the wax dissolution and the mixing of the essential components occur precisely at high temperatures, only the priming of the high string expression can be performed well, the amplification of various gene samples can be performed at the same time, And the storage of the reaction mixture is easy. However, there is a problem that the above method is troublesome to handle and takes a long time (Non-Patent Document 1).
In addition, since the mineral oil used as the evaporation blocking film contaminates the PCR sample and appears as a non-DNA-containing band, it becomes difficult to quantitatively analyze the PCR data. Therefore, an improvement has been made to use only paraffin beads for hot start PCR. Since the paraffin beads form a solid layer at 55 ° C or lower, the primer and the template DNA are mixed only when the primer and the template DNA are not mixed at room temperature and the reaction temperature is higher than the melting point of paraffin, Can be increased. In addition, the use of paraffin beads has been preferred as a method for improving hot start PCR because paraffin is present at the bottom of a microcentrifuge tube and is easy to collect and sample at low cost (Non-Patent Document 2).
Another hot start PCR method is to use petroleum jelly such as AmpliGrease instead of paraffin wax. This method is also analogous to the method of using wax and oil, in which the reaction mixture is separated into two layers, a bottom mix and a top mix, with petroleum jelly therebetween, Is different from the method using a conventional wax in that petroleum jelly starts to melt at a lower temperature condition (melting point of about 50 ° C) than wax to form a solution and is not hardened again by cooling (Non-Patent Document 3). However, this method has a limitation that it can be applied only to a small volume sample because the mixing efficiency does not occur due to the difference in density between the upper and lower mixture when the amount of the sample is large.
In addition, various organic solvents (PEG, DMSO, Glycerol, etc.) used as a PCR promoter may be used in combination with a reaction bead prepared by coating a reaction mixture dried with a trehalose solution with wax (Non-Patent Document 4) To increase the efficiency of hot start PCR (Non-Patent Document 5).
Currently, the most widely used hot start method is to induce hot start PCR reaction by controlling the activity of DNA polymerase using an antibody against DNA polymerase. That is, at a low temperature (20 ° C to 40 ° C), the anti-DNA polymerase antibody binds to the DNA polymerase to inactivate the function of the DNA polymerase, and at a high temperature (70 ° C to 80 ° C) The DNA polymerase which has been activated by the destruction of the antibody participates in the polymerization reaction, so that the production of primer-dimer or nonspecific product can be reduced and the yield and sensitivity of PCR can be increased (Non-Patent Document 6). The primer dimer and nonspecific reaction generally occur from the mixing of the PCR reaction to the DNA denaturation step, and also occur generally in the DNA denaturation step in the PCR reaction, the primer annealing step, the primer annealing step, and the DNA polymerase activity step .
In addition, there is an example in which a new DNA polymerase (AmpliTaqGold, Perkin-Elmer, USA) is applied to human platelet alloantigen typing. Since this polymerase is activated only by heat, hot start PCR is possible, It has been reported that the amplification can be prevented (Non-Patent Document 7).
In addition, there is a method of inducing hot start PCR reaction by suppressing the reaction of Mg 2 + at low temperature by using pyrophosphate and pyrophosphatase. As fatigue phosphatase and sikineunde Looking at the hot start PCR mechanism of pyrophosphate, phosphate blocks the Mg 2 + ions in the reaction components for PCR reaction fatigue, the Mg 2+ ions are components required when the DNA polymerase exhibit activity, As a result, the activity of the DNA polymerase gradually decreases. At this time, since pyrophosphate and Mg 2 + ions have high affinity, when pyrophosphate is added to the PCR mixture, Mg 2 + ions required for performing the PCR reaction are captured by pyrophosphate, and the PCR reaction is stopped The reaction by the DNA polymerase is no longer carried out. As a result, even if the priming of the low string expression occurs, the resulting nonspecific amplification product is not generated. Inhibition of the reaction by added pyrophosphate can be resolved by adding a certain amount of pyrophosphatase to the PCR mixture, which slowly dissociates the bond between pyrophosphate and Mg 2 + . At this time, pyrophosphatase removes the bond between pyrophosphate and Mg 2 + to generate free Mg 2+ ions, so that the PCR reaction inhibited by pyrophosphate can proceed again. Fatigue phosphatase Since stable heat at a specific temperature (above 70 ℃), fatigue phosphatase and DNA polymerase by expressing the enzyme activity under the same temperature conditions, the glass by fatigue phosphatase Mg 2 + ion broken away is a DNA polymerase To appropriately amplify the desired product by using the PCR reaction to inhibit the production of nonspecific amplification products (Patent Document 1).
In addition, a method using DNA plasmids binding to DNA polymerase has been developed (Patent Document 2). As for the mechanism of action, DNA plasmids are used as a substrate for DNA polymerase to bind with DNA polymerase. The bound DNA polymerase stops the polymerization reaction, and the polymerization reaction does not occur at the temperature before the DNA aptamer is denatured. When the reaction temperature rises, the DNA aptamer is denatured, and thus the DNA polymerase is activated to initiate the polymerization reaction. However, the above method has an advantage that the PCR reaction can be carried out immediately, but it is possible to cause a nonspecific reaction due to the long length of the extramammary.
There is also known a PCR method using a DNA polymerase inhibitor consisting of a nucleic acid sequence that partially forms a double bond, which plays a role of preventing DNA polymerase activity by binding to a DNA polymerase at a specific temperature or lower Literature 3).
As described above, many studies have been conducted on hot start PCR, and although it has recognized the necessity, it has not been applied to various experiments because of economical efficiency and various limited factors in use, and also DNA polymerase, Antibody, and pyrophosphatase are all proteins, so that they require a lot of cost and time in terms of stability and supply and demand. In addition, since the above conventional methods have a fundamental limitation in preventing extension of the primer through formation of a primer-dimer or the like, it is somewhat insufficient to prevent generation of a nonspecific amplification product due to extension of the primer there was.
The present invention has been made to overcome the problems of the prior art as described above, and it is an object of the present invention to provide a composition for PCR which can be obtained by further adding a blocking oligonucleotide having a predetermined concentration having a base sequence complementary to a primer, It is an object of the present invention to provide a composition for hot start PCR which can suppress the occurrence of primer-dimer formation at temperature or a smeared band of PCR amplification product due to nonspecific reaction to obtain more accurate PCR result.
The present invention provides a composition for hot start PCR comprising a blocking oligonucleotide.
The composition for hot start PCR of the present invention is characterized in that a composition for PCR comprising a reaction buffer solution, MgCl 2 , four dNTPs and a DNA polymerase is added to a blocking oligonucleotide having a base sequence complementary to the primer, Nucleotides. The composition for PCR may further include a primer, a probe, a template nucleic acid, a fluorescent dye, a reverse transcriptase and the like, if necessary. In the present invention, the term "template nucleic acid" is used to include without limitation DNA, RNA, hybrid of DNA and RNA, and the like.
In the present invention, the blocking oligonucleotide is characterized in that the number of base sequences is smaller than that of a primer having a complementary base sequence. Thus, when the nucleotide sequence of the blocking oligonucleotide is smaller than the nucleotide sequence of the primer, the melting temperature of the primer (or the template nucleic acid) -blocking oligonucleotide bond becomes lower compared to the melting temperature of the primer-template target DNA binding . Therefore, although the primer and the blocking oligonucleotide are bonded with a double helix at a low temperature, the blocking oligonucleotide having a somewhat lower denaturation temperature is disassociated before the annealing temperature of the primer, It has no effect at all and can be usefully used for hot start PCR. The method using such a blocking oligonucleotide can be applied to the probe in the same manner. According to one embodiment of the present invention, the blocking oligonucleotide preferably has a melting temperature lower than the primer by 1 ° C or more, preferably 2 ° C or more, and is preferably at least 25 ° C, .
In addition, the blocking oligonucleotide is characterized in that the hydroxyl group at the 3 'end is substituted with a substituent other than the hydroxyl group. The DNA polymerization proceeds in such a manner that the hydroxyl group at the 3 'end and the phosphate group at the 5' end are combined. Thus, when the hydroxyl group at the 3 'end is substituted with another substituent, the DNA polymerization reaction does not proceed any more. According to one embodiment of the present invention, the above-mentioned substituents include C3-Space represented by Chemical Formula 1, C6-space represented by Chemical Formula 2, C12-space represented by Chemical Formula 3, C18- 5, a phosphate represented by the formula (6), digoxigenin (DIG), thiol, and the like may be used, but the present invention is not limited thereto.
Also, according to one embodiment of the present invention, the first base at the 5 'end of the blocking oligonucleotide forms a complementary bond with the first base at the 3' end of the primer that binds complementarily to the blocking oligonucleotide , It is preferred that one or more bases at the 5'end of the blocking oligonucleotide remain unpaired by forming a complementary bond with the second and subsequent bases of the 3'end of the primer. That is, it is preferable that the base at the 5 'end of the blocking oligonucleotide forms a complementary bond to the base at the 3' end of the primer. If at least one base at the 5 'end of the blocking oligonucleotide remains unbound, DNA polymerization will occur from the 3' end of the primer to the first base at the 5 'end of the blocking oligonucleotide, As a result, the length of the primer can be further increased. When such a primer having an increased length is present in the reaction solution, it is not preferable because a non-specific amplification product resulting from primer-dimer formation, which has been a problem in the prior art, may be further increased.
The blocking oligonucleotide may be specifically bound to either a forward primer or a reverse primer for a pair of primers having a complementary sequence or may be specifically bound to both the forward primer and the back primer .
In the present invention, the reaction buffer solution is preferably 10 mM TrisHCl, 40 mM KCl, pH 9.0. The four dNTPs represent dATP, dTTP, dGTP and dCTP. The DNA polymerase can be any known DNA polymerase without limitation. Among them, a polymerase having 5 '-> 3' exonuclease activity, a polymerase having 3 '-> 5' exonuclease activity Enzymes and 5 '-> 3' exonuclease activity and 3 '-> 5' exonuclease activity can be used alone, or the DNA polymerase can be used in combination. Examples of the polymerase having the 5 '-> 3' exonuclease activity include Taq DNA polymerase and examples of the polymerase having 3 '-> 5' exonuclease activity include Pfu DNA polymerase or TLA DNA polymerase Examples of polymerases without enzyme, 5 '-> 3' exonuclease activity and 3 '-> 5' exonuclease activity include, but are not limited to, Top DNA polymerase. The DNA polymerase can be used in the PCR composition in a concentration of 0.1 to 10 U (unit), preferably 0.5 to 2 U, most preferably 1 U.
Meanwhile, the composition for hot-start PCR of the present invention may further include a non-reactive dye substance for convenience of experiment, prevention of contamination by PCR reaction product, stabilization of DNA polymerase and dNTP and improvement of reactivity have. The non-reactive dye material should be selected from materials that do not affect the PCR reaction. Examples of materials that satisfy these conditions include bromophenol blue, xylene cyanole, bromocresol red, cresol red and the like. The non-reactive dye material may be contained in an amount of 0.0001 to 0.01% by weight, preferably 0.001 to 0.005% by weight, and more preferably 0.001 to 0.003% by weight based on the total composition . When the non-reactive dye material is added in an amount of less than 0.0001% by weight, there is a problem that the concentration of the dye is low during agarose gel electrophoresis for analysis after the PCR reaction and it is difficult to visually observe the movement of the sample. When the reactive dye material is added in an amount exceeding 0.01% by weight, a high concentration of the water-soluble dye may act as a reaction inhibitor during the PCR reaction. In addition, there is a problem that after the sedimentation of the agarose gel, the movement of the sample during electrophoresis may be interrupted.
In addition, the composition for hot start PCR of the present invention may contain a reverse transcriptase for synthesizing cDNA as required. Thus, in the case of reverse transcription-PCR containing reverse transcriptase, it is preferable to add a blocking oligonucleotide to the sense primer of the amplified RNA in the composition for hot start PCR of the present invention.
DNA polymerase is an enzyme that binds to the 3 'terminal part of a partial double helix structure with a single end at the 5' end to cause a polymerization reaction. In the present invention, blocking oligos were designed in consideration of the characteristics of such DMA polymerase. In the present invention, by designing the 5'end of the blocking oligonucleotide to be complementary to the 3'end of the primer, it is possible to prevent the primer from further reacting nonspecifically and to prevent the primer from hybridizing to another nucleic acid to elongate the base. In addition, the 3'end of the blocking oligonucleotide was made shorter than the 5'end of the primer so that the DNA polymerase was adhered well, and the 3'hydroxyl group was blocked with another substituent to prevent the blocking oligo from stretching. Thus, by simply adding the blocking oligonucleotide to the reaction product, the DNA polymerase is attached to the double helix of the primer and the blocking oligonucleotide and can no longer perform a nonspecific reaction, so that the extension reaction of the primer can be prevented at room temperature do.
The blocking oligonucleotide used in the hot start PCR composition of the present invention is an oligonucleotide having a nucleotide sequence complementary to a primer or a probe. The oligonucleotide has a shorter length than the primer / probe and has a primer / So that the DNA polymerase recognizes and binds as a substrate, but DNA polymerization does not occur because the 3 'end is blocked. Therefore, it is possible to prevent non-specific PCR products from occurring by suppressing nonspecific polymerization of primers, which may be a problem in a conventional PCR reaction. Therefore, when the composition for hot-start PCR of the present invention is used, unlike the hot start PCR method using an antibody such as a conventionally used antibody, chemical modification, or pyrophosphate, the primer and target template DNA double- Since the polymerase is released immediately after the temperature is lowered, the PCR reaction can be performed immediately without consuming the incubation time for activation.
As for the mechanism of action of the blocking oligonucleotide, forward and reverse primers serve as essential elements in the PCR reaction. The blocking oligonucleotide is an oligonucleotide composed of a complementary base sequence having one to fewer nucleotides than the forward primer and the reverse primer, so that the specificity for the primer is high. Therefore, when the forward / reverse primer and the blocking oligonucleotide are mixed, the blocking oligonucleotide binds to the forward / reverse primer to prevent the forward / reverse primer from acting, thereby preventing primer dimer formation and non-specific reaction . When the temperature reaches the optimum temperature, that is, the melting temperature of the blocking oligomer, the binding between the primer and the blocking oligonucleotide is broken, so that the primer binds to the target template nucleic acid, so that the PCR reaction can be accurately and effectively performed. That is, since the blocking nucleotides are produced in a relatively shorter length than the primer / probe, when the primer reaches the proper temperature at which the primer binds to the template nucleic acid, the blocking nucleotide dissociates from the primer / probe and therefore does not affect when the primer binds to the template (See FIG. 1).
The hot start PCR method using the blocking oligonucleotide of the present invention can be usefully applied in the following cases, but is not limited thereto.
Ⅰ. When there is a drag of the PCR amplification product due to a nonspecific reaction in monoplex PCR reaction.
Ⅱ. When multiple amplification products are generated by nonspecific reactions in a PCR reaction.
Ⅲ. When the efficiency of PCR reaction is lowered by the primer dimer.
IV. When you want to increase PCR efficiency for specific targets with low amplification.
Ⅴ. To identify one or more amplification products (Multiplex PCR).
VI. When you want to improve the efficiency of PCR reaction for specific target in fields such as quarantine and disease diagnosis.
VII. When performing real-time PCR reactions that require specificity.
VIII. When primers with different Tm values are used specifically.
Ⅸ. When a nonspecific amplification product occurs in a One-Step RT-PCR reaction.
In addition, the composition for hot start PCR of the present invention has the following advantages in comparison with various PCR compositions reported in the past.
1) Since the reaction can proceed according to the general PCR method, long-term pretreatment at a high temperature is not required.
2) It is more economical than conventional PCR composition.
3) Since it prevents the generation of amplification product by priming of low string expression, it can be applied to multiplex PCR reaction using various samples at the same time.
In addition, the present invention provides a hot start PCR method using the hot start PCR composition.
The hot start PCR method is characterized in that a hot start PCR reaction is performed after addition of a blocking oligonucleotide as described above to a composition for ordinary hot start PCR. According to one embodiment of the present invention, the composition for hot-start PCR of the present invention can be used in addition to conventional PCR, such as multiplex PCR, real-time PCR, real-time quantitative PCR, real-time RT / May be used without limitation. "Multiplex PCR" as used herein means to simultaneously amplify one or more multiple DNA targets in one polymerase chain reaction (PCR) mixture.
It is generally difficult to design multiplex PCR conditions that simultaneously amplify two or more target sequences because it is desirable to design an optimal PCR reaction so that both of the two or more target sites can be amplified without nonspecific byproducts . In this case, annealing is required to be performed at a sufficiently high temperature in order to obtain a perfect template DNA-primer match, and it is also necessary to design such that annealing does not occur between two or more pairs of primers. In the case of multiplex PCR, the PCR efficiency is lowered by nonspecific reaction and primer dimer when there is no hot start function, and it is difficult to obtain accurate results by nonspecific amplification products. Therefore, hot start method is widely applied, . The hot start PCR method of the present invention is ideal for optimization of multiplex DNA amplification by adding a blocking oligonucleotide having a base sequence complementary to each target primer to improve the specificity of amplification.
In one embodiment of the invention, the amplified products from each of the target nucleotide sequences have been designed differently for later analysis, so that the amplification products of the multiplex target nucleotide sequence can be easily analyzed through size discrimination. Size fractionation comparisons may be performed through a variety of known methods, i.e., electrophoresis through a polyacrylamide gel matrix or an agarose gel matrix. By using the blocking oligonucleotides of the present invention, background problems as well as non-specificity problems of conventional multiplex PCR methods can be eliminated.
The advantage of multiplex PCR is that many diseases can be analyzed simultaneously in the same reaction. Theoretically, there are no limitations on the number of analytes that can be analyzed at the same time, but in practice, about 20 are the upper limit because they depend on the size difference required for analysis and how the amplified product can be analyzed. The method of the present invention can be applied to diagnosis of genetic and infectious diseases, sex determination, genetic association analysis, and research on crime science.
As described above, in contrast to the conventional hot start PCR method using an antibody, chemical modification, or pyrophosphate, the composition for hot start PCR of the present invention has a blocking oligonucleotide dissociated below the melting temperature of the primer Therefore, it is advantageous in that more accurate PCR result can be obtained by suppressing primer-dimer formation at a low temperature or a drag phenomenon of a PCR amplification product due to nonspecific reaction.
1 is a schematic diagram showing a nonspecific reaction inhibitory effect by a blocking oligonucleotide.
FIG. 2 shows non-specific reaction inhibitory effect according to the length of the blocking oligonucleotide. As a positive control, A and H were confirmed to inhibit nonspecific reaction by hot start function using a product having a hot start function. C, G, and I to M were determined as 18 ° C, 26 ° C, 34 ° C, 37.4 ° C, 40.9 ° C, 46.1 ° C, 48.6 ° C and 50.5 ° C, respectively,
FIG. 3 is a graph showing a non-specific inhibitory effect of blocking oligonucleotides according to the concentration used; A is a result of using a product having no hot start function as a negative control, and B is a positive control, And
FIG. 4 shows the results of confirming the nonspecific reaction inhibitory effect by adding an oligonucleotide blocking the forward or reverse primer, wherein A is a result of using a product having no hot start function as a negative control, and B is a positive control, C and D are the result of addition of a blocking oligonucleotide having a nucleotide sequence complementary to that of the forward primer, and E and F are the results obtained by adding a blocking oligonucleotide having a complementary nucleotide sequence of the reverse primer G is the result of addition of a blocking oligonucleotide having a nucleotide sequence complementary to the forward and reverse primers,
FIG. 5 is a graph showing the results of using a product having a hot start function as a positive control group and B to G in the case of using amines, phosphates, C3-
Fig. 6 shows the effect of inhibiting nonspecific reaction depending on presence or absence of a blocking oligonucleotide in a product which does not have a hot-start function in case (A) and (B)
FIG. 7 shows the result of multiplex PCR reaction according to addition of blocking oligonucleotide. It was confirmed that PCR reaction inhibition was confirmed by adding a blocking oligonucleotide to a product having a hot start function, and addition of a blocking oligonucleotide to a product without a hot
Figure 8 shows the nonspecific inhibitory effect of blocking oligonucleotide addition in the One-Step RT / PCR reaction.
FIG. 9A shows primer dimers and nonspecific inhibitory effects upon addition of a blocking oligonucleotide in a real-time PCR reaction. In the PCR Premix solution containing Taq DNA polymerase, a fluorescent material (Sybrgreen I) and a base complementary to the primer (Experimental group) with addition of a blocking oligonucleotide having a sequence and a fluorescent primer solution containing only Taq DNA polymerase (control group), fluorescence measurement curves obtained by real-time PCR reaction , The horizontal axis represents the PCR reaction cycle, the vertical axis represents the measured fluorescence value according to the reaction cycle, the line I represents the fluorescence detection curve for the control group, and the line II represents the fluorescence detection curve for the experimental group. 9 (B) is a graph showing the result of forming a melting curve by using a fluorescence measurement curve, wherein the horizontal axis represents the temperature change and the vertical axis represents the measured fluorescence value according to the temperature increase, and line I represents the result of the melting curve creation And line Ⅱ shows the result of creating the melting curve for the experimental group.
Hereinafter, the present invention will be described in more detail by way of examples.
However, the following examples are for illustrative purposes only and are not intended to limit the scope of the present invention.
Example 1. Inhibitory effect of nonspecific amplification product formation on blocking oligonucleotide Tm value
In order to confirm the inhibitory effect of nonspecific amplification products depending on the length of blocking oligonucleotides having a nucleotide sequence complementary to a primer, which is a necessary element of the PCR reaction, PCR products were compared after addition of blocking oligonucleotides of various lengths. For this, primers were designed and synthesized as shown in Table 1, and human genomic DNA (10 ng), each primer (10 pmoles) and a primer (2 pm to 15 pm) were added to a PCR premix (PreMix) The PCR reaction was carried out by adding blocking oligonucleotides (10 pmoles each) having various lengths with a low Tm value. PCR was performed 30 times at 95 ° C for 20 seconds, at 55 ° C for 40 seconds, and at 72 ° C for 60 seconds. The pre-denaturation and final elongation were 5 minutes at 94 ° C, 5 minutes at 72 ° C Respectively. The product obtained in the PCR reaction was electrophoresed on an agarose gel together with a DNA molecular weight marker, stained with ethidium bromide, and a DNA band amplified by a PCR reaction was photographed with a Polaroid camera. AccuPower Hotstart PCR Premix with hot start function, Bioneer Co., Ltd.), Hot start functionless PCR primer (AccuPower PCR Premix PCR) was used as a negative control, The PCR reaction was performed by adding blocking oligonucleotides. The results are shown in Fig.
2,
Blocking oligo
3 'Amine modification
As a result, when a blocking oligonucleotide having a nucleotide sequence complementary to that of the primer is added at the time of performing the PCR reaction, the activity of the DNA polymerase is blocked, and the primers for low stringency generated by mixing the components required for gene amplification at room temperature And to thereby reduce the production of nonspecific amplification products (FIG. 2).
Example 2. Nonspecific amplification product formation inhibition effect depending on the concentration of blocking oligonucleotide
The template-specific primer of Example 1 and the 20-mer P55 blocking oligonucleotide of SEQ ID NO: 12 were used to confirm the appropriate concentration of the blocking oligonucleotide. The PCR reaction was carried out in the same manner as in Example 1, except that the template-specific primer was used at a concentration of 20 pmoles and the blocking oligonucleotide was used at a concentration of 5 pmoles to 30 pmoles. The results are shown in Fig.
3,
As a result, in the PCR reaction, nonspecific reaction and resulting smeared band of the PCR amplification product were observed when the PCR reaction without the hot start function as the negative control group was performed, whereas the hot start It was confirmed that PCR amplification products with more accurate and clean PCR products were produced when performing functional PCR reaction. Also, when blocking oligonucleotides at various concentrations are added to the negative control group, the same effect as that of the hot start PCR reaction can be obtained. When the blocking oligonucleotide is used at the same or lower concentration than the template DNA target primer, the activity of the polymerase is blocked, And to suppress the nonspecific reaction effect (FIG. 3).
Example 3. Forward and / or reverse Primer and Inhibitory Effect of Blocking Oligonucleotides Having Complementary Nucleotide Sequence on Nonspecific Amplification Products
In principle, the PCR reaction can not occur unless primers of any one of the forward and reverse primers are present. Therefore, the effect on the nonspecific reaction was confirmed after the addition of the blocking oligonucleotide blocking any one or more of the forward or reverse primers of the target primer. To this end, PCR reaction (A) without hot start function as a negative control, PCR reaction (B) with hot start function as a positive control, reverse blocking oligonucleotide added to the negative control (C and D) (E and F) added with blocking oligonucleotides, or both forward and reverse blocking oligonucleotides added) G) was subjected to PCR reaction in the same manner as in Example 2. At this time, the primer and the blocking oligonucleotide were used at the same concentration of 10 pmole.
As a result, non-specific amplification products were confirmed in the negative control group without hot start function (A), whereas non-specific amplification products could not be confirmed in the positive control group with hot start function (B). It is also possible to suppress the nonspecific amplification reaction by adding either one instant blocking nucleotide in the forward direction (C and D) or the reverse direction (E and F), or adding both instant blocking nucleotides (G) It was confirmed that the DNA banding phenomenon caused by the product did not occur (Fig. 4).
Example 4. Nonspecific reaction inhibition effect by various kinds of modified blocking oligonucleotides
The hot start effect of the blocking oligonucleotide was confirmed after applying various substituents to the 3 'end of the blocking oligonucleotide. The substituents used are shown in Table 2 below, and the PCR reaction was carried out in the same manner as in Example 2. The results are shown in Fig.
In Fig. 5,
As a result, it was confirmed that a nonspecific amplification reaction can be inhibited even when a chemical substance capable of blocking a DNA polymerase is introduced at the 3 'side of a blocking oligonucleotide having a nucleotide sequence complementary to the primer (FIG. 5) .
Example 5. Nonspecific reaction inhibition effect of blocking oligonucleotide under severe conditions that may cause nonspecific reaction
The result (Ⅱ) of the hot start PCR reaction using the blocking oligonucleotide and the result (Ⅰ) of the general PCR reaction without the blocking oligonucleotide as the control group were compared. For this, PCR was carried out on the hot-start PCR reaction mixture containing the blocking oligonucleotide prepared in Example 2 under the same conditions as in Example 2, and a part of the PCR reaction was carried out at 37 ° C for 1 hour The PCR reaction was carried out under the same conditions as in Example 2. The results are shown in FIG. The nucleotide sequence pairs of the template-specific oligonucleotides used are shown in Table 3.
As a result, in the PCR reaction using the instant hot start PCR reaction mixture, a clean amplification product was produced with no nonspecific PCR amplification product as compared with the control (Fig. 6A). In addition, the instant hot start PCR reaction mixture using the control and blocking oligonucleotides was reacted at 37 ° C for 1 hour and the PCR reaction was carried out. As a result, a nonspecific amplification product was observed in the control group irrespective of the reaction at 37 ° C for 1 hour , The amplification efficiency was decreased regardless of the harsh temperature condition (reaction at 37 ° C for 1 hour) in the PCR reaction using the blocking oligonucleotide, and the DNA band caused by the nonspecific amplification product did not occur 6, B). From the above results, it can be seen that, when an instant hot start PCR reaction comprising a blocking oligonucleotide is performed, generation of nonspecific amplification products can be effectively suppressed under normal temperature conditions as well as harsh conditions in which nonspecific amplification products are frequently generated Respectively.
Example 6. Hot start PCR How to Multiplex PCR Application to
In order to confirm whether or not the composition for hot start of the present invention can be applied to multiplex PCR, six primer pairs for six target nucleotide sequences and a blocking oligonucleotide for the primers were added, followed by primer annealing , Primer extension and denaturation. The nucleotide sequences of the primers and the blocking oligonucleotides used in this Example are shown in Table 4. An instant hot start PCR reaction with blocking oligonucleotides was performed in the PCR premix without hot start, and a hot start PCR premix was used as a control. Human genomic DNA (100 ng and 10 ng) was used as a template. The results are shown in Fig.
In FIG. 7,
As a result, it was confirmed that the PCR reaction of the hot start PCR premix was not inhibited even when the blocking oligonucleotide was added. In addition, in the case of a PCR primer without a hot-start function, when a blocking oligonucleotide is added, all target sequences are amplified or background problems are eliminated, in contrast to a case in which some target sequences are not amplified or weakly amplified, It was confirmed that the PCR reaction could be realized (Fig. 7).
Example 7. One - step RT / PCR Inhibition of nonspecific reaction by blocking oligonucleotide in reaction
The inhibitory effect of blocking oligonucleotide on nonspecific reaction was confirmed in one-step RT / PCR reaction. For this purpose, 100 ng of human total RNA was used as the template RNA, and the target gene was a GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor). The target primer and the blocking oligonucleotide used in Table 5 were used. As a control group, AccuPower Hotstast RT / PCR Premix (Bioneer) and hot-start AccuPower RT / PCR Premix (Bioneer) were used. Hot-start AccuPower RT / The PCR reaction was performed by adding a blocking oligonucleotide having a nucleotide sequence complementary to the forward primer to the PCR primer. The results are shown in Fig.
In Figure 8, lane M is the DNA size marker,
As a result, it was confirmed that a nonspecific reaction similar to the hot start function was suppressed by adding a blocking oligonucleotide to an AccuPower RT / PCR premix without a hot start function (FIG. 8).
Example 8. Real time PCR By blocking oligonucleotides in the reaction primer Dimer Inhibitory effect
In order to confirm the hot start effect by the PCR composition containing the blocking oligonucleotide in the real-time PCR detection, 2x PCR Premix solution (10 mM TrisHCl pH 9.0, 50 mM KCl, 2.0 mM MgCl 2 , , 1 U Taq DNA polymerase, 0.01% Tween 20, and a stabilizer) was added at a concentration of 0.3 X per reaction, and 20 pmoles of blocking agent (Greenstar (TM), Bioneer) A composition to which the oligonucleotide was added was prepared. As a control, the fluorescent substance was added to the 2x PCR Premix solution so as to be 0.25x per 20 μl reaction. The fluorescent substance is a fluorescent substance which can be easily analyzed without measuring a fluorescent probe having a specific base sequence by measuring the amount of fluorescence generated by intercalation between double-stranded DNAs generated during template DNA amplification. As the template DNA, 100 ng of total RNA extracted from human cells was added to AccuPower CycleScript RT PreMix (Bioneer Co., Ltd.), reacted at 42 ° C for 1 hour, and then the reverse transcriptase-inactivated
The real-time PCR reaction was performed using an Exicycler 96 Real-Time Quantitative Thermal Block (Bioneer, Inc.). The reaction conditions were a denaturation step at 94 ° C for 5 minutes, a denaturation step at 95 ° C for 10 seconds , The annealing step at 60 캜 for 15 seconds, and the simultaneous reaction of the elongation step were carried out in a total of 45 reaction cycles as one reaction cycle. Thereafter, the dissociation step was performed to prepare a melting curve for the amplification product, thereby confirming PCR reactivity and specificity for the PCR amplification product. The results are shown in Fig.
As a result, the threshold cycle (Ct) for line I and line II was found to be 23.89 C (t) and 29.5 C (t), respectively. The fact that C (t) was drawn on line I rather than on line II showed that only one fluorescent peak was produced in line II containing blocking oligonucleotides as shown in the melting curve, while only the correct amplification product was produced, while blocking oligonucleotides This is because two fluorescence peaks appear, indicating that two amplification products were generated. This means that in addition to the desired PCR amplification product, a smaller size primer dimer amplification product or a nonspecific amplification product was generated. Also, the melting temperature (Tm) for the PCR amplification product was confirmed to be 85.5 ° C in both the experimental group (line II) and the control group (line I), and the melting temperature (Tm) for the primer dimer or non- 75.5 캜.
From the above results, in contrast to the case where the primer dimer is generated in addition to the amplification product in the case of the control group, the instant hot-start PCR method used in the present invention shows a low temperature and a nonspecific reaction during the PCR reaction Inhibited the PCR reaction effectively and restrained the production of nonspecific PCR amplification products, which is an advantage of the hot start method, and confirmed the accurate results.
Attach an electronic file to a sequence list
Claims (15)
Wherein the blocking oligonucleotide has a smaller number of base sequences than a primer having a complementary base sequence.
Wherein the blocking oligonucleotide has a lower melting temperature than the primer having a complementary base sequence.
Wherein the blocking oligonucleotide has a melting temperature lower than that of the primer having a complementary base sequence by at least 1 占 폚.
Wherein the blocking oligonucleotide has a melting temperature of at least < RTI ID = 0.0 > 25 C. < / RTI >
Wherein the blocking oligonucleotide has a hydroxyl group at the 3 'terminal thereof substituted with a substituent other than the hydroxyl group.
The substituent may be selected from the group consisting of a C3-Space represented by Chemical Formula 1, a C6-space represented by Chemical Formula 2, a C12-space represented by Chemical Formula 3, a C18-Space represented by Chemical Formula 4, an amine represented by Chemical Formula 5, DIG (Digoxigenin), and thiol. ≪ RTI ID = 0.0 > 11. < / RTI >
[Chemical Formula 1]
(2)
(3)
[Chemical Formula 4]
[Chemical Formula 5]
[Chemical Formula 6]
Wherein the base at the 5 'end of the blocking oligonucleotide forms a complementary bond to the base at the 3' end of the primer.
Wherein the blocking oligonucleotide specifically binds to at least one of a forward primer and a back primer.
Wherein the DNA polymerase is selected from the group consisting of a polymerase having a 5'->3'exonuclease activity, a polymerase having a 3'->5'exonuclease activity and a 5'->3'exonuclease activity and a 3'- Gt; 5 ' exonuclease activity. ≪ / RTI >
Lt; RTI ID = 0.0 > 1, < / RTI > further comprising a dye material that is non-reactive with the template nucleic acid.
Wherein the non-reactive dye material is selected from the group consisting of bromophenol blue, xylenecyanol, bromocresol red, and cresol red.
Lt; RTI ID = 0.0 > 1, < / RTI > further comprising a reverse transcriptase.
Wherein said PCR is selected from the group consisting of multiplex PCR, real-time PCR, real-time quantitative PCR, real-time RT / PCR and real-time quantitative RT / PCR.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20110017226A KR101424192B1 (en) | 2011-02-25 | 2011-02-25 | Composition for Hot-start PCR Comprising Blocking Oligonucleotide |
PCT/KR2012/001387 WO2012115464A2 (en) | 2011-02-25 | 2012-02-23 | Composition for hot-start pcr comprising blocking oligonucleotide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20110017226A KR101424192B1 (en) | 2011-02-25 | 2011-02-25 | Composition for Hot-start PCR Comprising Blocking Oligonucleotide |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120097793A KR20120097793A (en) | 2012-09-05 |
KR101424192B1 true KR101424192B1 (en) | 2014-07-28 |
Family
ID=46721349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR20110017226A KR101424192B1 (en) | 2011-02-25 | 2011-02-25 | Composition for Hot-start PCR Comprising Blocking Oligonucleotide |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101424192B1 (en) |
WO (1) | WO2012115464A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102124058B1 (en) | 2013-09-16 | 2020-06-17 | 삼성전자주식회사 | Polynucleotide and use thereof |
WO2015063154A1 (en) * | 2013-10-31 | 2015-05-07 | Multiplicom N.V. | Blocking primers in multiplex pcr based assays |
LT3402880T (en) | 2016-01-15 | 2024-03-12 | Thermo Fisher Scientific Baltics Uab | Thermophilic dna polymerase mutants |
EP3402826A1 (en) * | 2016-01-15 | 2018-11-21 | Thermo Fisher Scientific Baltics UAB | Antibodies that bind thermophilic dna polymerases |
KR101897490B1 (en) | 2016-12-02 | 2018-09-12 | 건국대학교 산학협력단 | A composition for PCR containing a polyethyleneglycol-engrafted nano-sized graphene oxide |
EP3645710A1 (en) | 2017-06-26 | 2020-05-06 | Thermo Fisher Scientific Baltics Uab | Thermophilic dna polymerase mutants |
KR102141312B1 (en) | 2019-04-19 | 2020-08-04 | 주식회사 제노헬릭스 | Small RNA-primed Xenosensor module amplification mediated small RNA detection method |
GB202012480D0 (en) * | 2020-08-11 | 2020-09-23 | Univ Oxford Innovation Ltd | Switch Oligonucleotide |
DE202020004407U1 (en) * | 2020-10-20 | 2020-11-24 | Friz Biochem Gmbh | Functionalized microtiter plate, reaction solution, and kit for preparing a reaction solution |
-
2011
- 2011-02-25 KR KR20110017226A patent/KR101424192B1/en active IP Right Grant
-
2012
- 2012-02-23 WO PCT/KR2012/001387 patent/WO2012115464A2/en active Application Filing
Non-Patent Citations (1)
Title |
---|
Nucleic Acids Res., Vol. 36, No. 20, page e131 (2008.11.30) * |
Also Published As
Publication number | Publication date |
---|---|
KR20120097793A (en) | 2012-09-05 |
WO2012115464A3 (en) | 2012-12-20 |
WO2012115464A2 (en) | 2012-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101424192B1 (en) | Composition for Hot-start PCR Comprising Blocking Oligonucleotide | |
EP1952792B1 (en) | Methods of using FET labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same | |
CA2594223C (en) | Primer for nucleic acid detection | |
AU2012374566B2 (en) | Polymerase chain reaction detection system using oligonucleotides comprising a phosphorothioate group | |
CN107849603A (en) | Expanded using the primer of limited nucleotides composition | |
US20070231809A1 (en) | Methods of Using FET Labeled Oligonucleotides That Include a 3'-5' Exonuclease Resistant Quencher Domain and Compositions for Practicing the Same | |
WO2009057931A2 (en) | Dried composition for hot-start pcr with long-term stability | |
KR102295290B1 (en) | Dna amplification technology | |
KR102323375B1 (en) | Multiplex Probes | |
EP4355908A1 (en) | A method to amplify and detect target nucleic acids with very high specificity and sensitivity | |
JP2012506246A (en) | RNA quantification using internal normalization | |
US11091802B2 (en) | Nucleic acid complex pair and target detection method using thereof | |
CN101671672A (en) | Polyanion for improved nucleic acid amplification | |
EP1777300B1 (en) | Organic salt additives for nucleic acid amplification | |
JP2006075167A (en) | Real time pcr accompanying addition of pyrophosphatase | |
CN102639719A (en) | Preferential amplification of mRNA over DNA using chemically modified primers | |
JP6523874B2 (en) | Nucleic acid amplification substrate, nucleic acid amplification method using the substrate, and nucleic acid detection kit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20170621 Year of fee payment: 4 |